RecallDepth
Class III Ongoing

Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9008-67

This recall is currently active, issued February 21, 2024. It was issued by Teva Pharmaceuticals Usa, Inc.

Company
Teva Pharmaceuticals Usa, Inc
Recall Initiated
January 25, 2024
Posted
February 21, 2024
Recall Number
D-0321-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
12,916 cartons
Firm Location
Parsippany, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.

Distribution

nationwide

Lot / Code Info

Lot #: 100042978, Exp 7/31/2024

More recalls by Teva Pharmaceuticals Usa, Inc

View all recalls by this company →

Other recent Class III Drug recalls